Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Transoral robotic surgery in head and neck cancer

Transoral robotic surgery in head and neck cancer Summary Robotic surgery in the field of head and neck cancer was initiated at the beginning of this century. In the last decade, transoral robotic surgery (TORS) had to prove its oncological equivalence to standardised conservative treatment regimens like radiotherapy and radiochemotherapy and to other transoral or open surgical procedures. The amount of data on oncological efficacy, cost effectiveness and long-term outcomes has continued to increase over the last few years. The transoral approach enables minimally invasive tumour resection, which helps to minimize functional postoperative deficits. Compared with traditional concurrent radiochemotherapy (CRCT), the radiation dose is lower in the adjuvant setting and therefore helps to reduce long-term toxicities. Moreover, in case of absent risk factors in the histological specimen, it might be possible to avoid additional chemotherapy. Thus, long-term toxicities eventually caused by CRCT might be decreased. http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png memo - Magazine of European Medical Oncology Springer Journals

Transoral robotic surgery in head and neck cancer

Download PDF
4 pages

Loading next page...
 
/lp/springer-journals/transoral-robotic-surgery-in-head-and-neck-cancer-BwH00FoPdW
Publisher
Springer Journals
Copyright
2020 Springer-Verlag GmbH Austria, part of Springer Nature
ISSN
1865-5041
eISSN
1865-5076
DOI
10.1007/s12254-020-00638-5
Publisher site
See Article on Publisher Site

Abstract

Summary Robotic surgery in the field of head and neck cancer was initiated at the beginning of this century. In the last decade, transoral robotic surgery (TORS) had to prove its oncological equivalence to standardised conservative treatment regimens like radiotherapy and radiochemotherapy and to other transoral or open surgical procedures. The amount of data on oncological efficacy, cost effectiveness and long-term outcomes has continued to increase over the last few years. The transoral approach enables minimally invasive tumour resection, which helps to minimize functional postoperative deficits. Compared with traditional concurrent radiochemotherapy (CRCT), the radiation dose is lower in the adjuvant setting and therefore helps to reduce long-term toxicities. Moreover, in case of absent risk factors in the histological specimen, it might be possible to avoid additional chemotherapy. Thus, long-term toxicities eventually caused by CRCT might be decreased.

Journal

memo - Magazine of European Medical Oncology – Springer Journals

Published: Dec 1, 2020

Keywords: oncology; medicine/public health, general

References

  • Transoral robotic surgery (TORS) for base of tongue neoplasms
    BW O’Malley, GS Weinstein, W Snyder
  • Experience in endoscopic laser surgery of malignant tumours of the upper aero-digestive tract
    W Steiner
  • Results of transoral laser microsurgery in 102 patients with squamous cell carcinoma of the tonsil
    M Canis, A Martin, M Kron
  • Results of transoral laser microsurgery for supraglottic carcinoma in 277 patients
    M Canis, A Martin, F Ihler
  • Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): an update on 93 randomised trials and 17,346 patients
    JP Pignon, A Maitre, E Maillard
  • Endoskopische Laserchirurgie der oberen Luft- und Speisewege. Schwerpunkt Tumorchirurgie
    W Steiner
  • Radiotherapy versus transoral robotic surgery and neck dissection for oropharyngeal squamous cell carcinoma (ORATOR): an open-label, phase 2, randomised trial
    AC Nichols, J Theurer, E Prisman
  • Quality of life outcomes of transoral robotic surgery with or without adjuvant therapy for oropharyngeal cancer
    R Sethia, AC Yumusakhuylu, I Ozbay
  • Systematic review of validated quality of life and swallow outcomes after transoral robotic surgery
    A Castellano, A Sharma
  • Transoral robotic surgery alone for oropharyngeal cancer: quality-of-life outcomes
    GW Choby, J Kim, DC Ling
  • Functional swallowing outcomes following treatment for oropharyngeal carcinoma: a systematic review of the evidence comparing trans-oral surgery versus non-surgical management
    N Dawe, J Patterson, J O’Hara
  • Transoral robotic surgery-assisted endoscopy with primary site detection and treatment in occult mucosal primaries
    KM Hatten, BW O’Malley, AM Bur
  • Transoral robotic surgery and the unknown primary: a cost-effectiveness analysis
    JK Byrd, KJ Smith, J Almeida
  • Trans-oral robotic assisted tongue base mucosectomy for investigation of cancer of unknown primary in the head and neck region. The UK experience
    SC Winter, E Ofo, D Meikle
  • One-year outcomes for da Vinci single port robot for transoral robotic surgery
    KM Abel, LX Yin, DL Price, JR Janus, JL Kasperbauer, EJ Moore
  • Next-Generation Robotic Head and Neck Surgery
    RK Orosco, A Arora, JP Jeannon
  • Spellman J, Coulter M, Kawatkar A, et al. Comparative cost of transoral robotic surgery and radiotherapy (IMRT) in early stage tonsil cancer. Am J Otolaryngol. 2020;102409.
    Spellman J, Coulter M, Kawatkar A, et al. Comparative cost of transoral robotic surgery and radiotherapy